ContraDyn Overview

  • Founded
  • 2006
  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Investors
  • 3

ContraDyn General Information


Developer of polymer drug delivery technology intended to treat tumors. The company's technology offers a nanoglobular drug delivery system for targeting tumors and chemotherapeutic agents for treating tumors without invasive surgery, enabling healthcare professionals to treat their patients with minimum pain.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Delivery
Primary Office
  • 615 Arapeen Drive
  • Suite 102
  • Salt Lake City, UT 84108
  • United States
+1 (801) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ContraDyn Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC Completed Generating Revenue
1. Grant 01-Jul-2008 00000 Completed Generating Revenue
To view ContraDyn’s complete valuation and funding history, request access »

ContraDyn Comparisons

HQ Location
Total Raised
Post Valuation
Last Financing Details
Developer of polymer drug delivery technology intended to treat tumors. The company's technology offers a nanoglobular d
Drug Delivery
Salt Lake City, UT
00000 00000


aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cil
00000 0000000 000 00000000

00 00000

esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt i
0000 000000000
Irvine, CA
00 As of 0000
000000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ContraDyn Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Bionomics Diagnostics Failed Transaction (M&A) Canada 000000000000
00 00000000 Venture Capital-Backed Irvine, CA 00 000.00 000000000000 000.00
To view ContraDyn’s complete competitors history, request access »

ContraDyn Executive Team (1)

Name Title Board Seat Contact Info
Zheng-Rong Lu Ph.D Scientific Founder
To view ContraDyn’s complete executive team members history, request access »

ContraDyn Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institutes of Health Government 000 0000 000000 0
Utah Centers of Excellence Government 000 0000 000000 0
UpStart Ventures (Salt Lake City) Venture Capital Minority 000 0000 000000 0
To view ContraDyn’s complete investors history, request access »